Under FDA, Unapproved Peptides Likely to Become More Widely Available (JAMA News)

JAMA News spoke to Pinchas Cohen regarding the possible lifting of FDA restrictions on mitochondria-derived peptides and mentioned his discovery of humanin, MOTS-c and numerous other MDPs. “To offer people the best way to address their health issues, we need to take them further into clinical trials,” Cohen said.